Clinical pharmacokinetics and metabolism of nimesulide

Inflammopharmacology

Volumn 9, Issue 1-2, 2001, Pages 81-89

  Bernareggi, A ^a  

^a Novuspharma SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4' HYDROXYPHENOXY) 4 NITROMETHANESULFONANILIDE; ALBUMIN; CYCLOOXYGENASE 2 INHIBITOR; NIMESULIDE; UNCLASSIFIED DRUG;

ADULT; CHILD; CONFERENCE PAPER; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG TRANSFORMATION; FEVER; HUMAN; INFLAMMATION; KIDNEY DISEASE; PAIN; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0034929039     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856001300248353     Document Type: Conference Paper

References (59)

1. Confronto di biodisponibilità tra due diverse forme farmaceutiche orali equidosate di nimesulide in volontari sani
2. Pharmacokinetics and pharmacodynamics of slow-release theophylline during treatment with nimesulide
3. A clinical assessment of the potential for pharmacological interaction between nimesulide and digoxin in patients with heart failure
4. Pharmacokinetics of nimesulide: Relative bioavailability of the rectal versus the oral administration. A single and repeated dose study in healthy volunteers
5. Bronchial inflammation and NSAIDs
6. Nimesulide binding to components within blood
7. Observations on the antirheumatic and physiologic effects of phenylbutazone and some comparisons with cortisone
8. Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs
9. Endoscopic assessment of the effects of nimesulide in the gastric mucosa: Comparison with indomethacin
10. Clinical pharmacokinetics of flurbiprofen and its enantiomers
11. Clinical pharmacokinetics of tiaprofenic acid and its enantiomers
12. Clinical pharmacokinetics of naproxen
13. Clinical pharmacokinetics of diclofenac
14. Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
15. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: An overview
16. First dose and steady-state pharmacokinetics of nimesulide and its 4-hydroxy metabolite in healthy volunteers
17. Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis
18. Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and COX 2 inhibitors
19. La nimesulide nel liquido sinoviale di paziente con artrite reumatoide
20. Dose-dependent pharmacokinetics of diflunisal in rats: Dual effects of protein binding and metabolism
21. Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs
22. Metabolism of nimesulide in man and radical scavenging activity of its main metabolites
23. Antioxidant activity of nimesulide and its main metabolites
24. In vitro metabolism of the anti-inflammatory drug nimesulide in man: Simultaneous determination of the main urinary metabolites by HPLC with UV-DAD detection
25. Differential inhibition of the cyclooxygenase activity of prostaglandin endoperoxyde synthase isozymes in vitro and ex vivo
26. Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs
27. Nimesulide in dysmenorrhoea
28. Distribution of oral nimesulide in female genital tissues
29. Nimesulide: Un farmaco antiinfiammatorio che inibisce selettivamente la cicloossigenasi 2
30. Safety profile of nimesulide: Ten years of clinical experience
31. Nonlinear plasma level response to high doses of naproxen
32. Renal effects of nimesulide in furosemidetreated subjects
33. Selective inhibition by nimesulide, a novel non-steroidal anti-inflammatory drug, with prostaglandin endoperoxide synthase-2 activity in vitro
34. Activity of nimesulide on constitutive and inducible cyclooxygenase, Arzneim
35. Effect of nimesulide on cyclo-oxygenase activity in rats' gastric mucosa and inflammatory exudate
36. Clinical and pharmacokinetic study of nimesulide in children
37. Effect of nimesulide action time dependence on selectivity towards prostaglandin G/H synthase/cyclooxygenase activity
38. Overview: Mechanisms of action of anti-inflammatory drugs
39. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs